BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 36228808)

  • 21. The multiple faces of cGAS-STING in antitumor immunity: prospects and challenges.
    Zhou Z; Huang S; Fan F; Xu Y; Moore C; Li S; Han C
    Med Rev (2021); 2024 Jun; 4(3):173-191. PubMed ID: 38919400
    [TBL] [Abstract][Full Text] [Related]  

  • 22. cGAS/STING: novel perspectives of the classic pathway.
    Gao M; He Y; Tang H; Chen X; Liu S; Tao Y
    Mol Biomed; 2020 Sep; 1(1):7. PubMed ID: 35006429
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cyclic GMP-AMP synthase is a cytosolic DNA sensor that activates the type I interferon pathway.
    Sun L; Wu J; Du F; Chen X; Chen ZJ
    Science; 2013 Feb; 339(6121):786-91. PubMed ID: 23258413
    [TBL] [Abstract][Full Text] [Related]  

  • 24. cGAS-STING signaling pathway in intestinal homeostasis and diseases.
    Yang Y; Wang L; Peugnet-González I; Parada-Venegas D; Dijkstra G; Faber KN
    Front Immunol; 2023; 14():1239142. PubMed ID: 37781354
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Positive feedback regulation of type I IFN production by the IFN-inducible DNA sensor cGAS.
    Ma F; Li B; Liu SY; Iyer SS; Yu Y; Wu A; Cheng G
    J Immunol; 2015 Feb; 194(4):1545-54. PubMed ID: 25609843
    [TBL] [Abstract][Full Text] [Related]  

  • 26. IFI16 and cGAS cooperate in the activation of STING during DNA sensing in human keratinocytes.
    Almine JF; O'Hare CA; Dunphy G; Haga IR; Naik RJ; Atrih A; Connolly DJ; Taylor J; Kelsall IR; Bowie AG; Beard PM; Unterholzner L
    Nat Commun; 2017 Feb; 8():14392. PubMed ID: 28194029
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Recent progress on the activation of the cGAS-STING pathway and its regulation by biomolecular condensation.
    Yu X; Zhao Z; Jiang Z
    J Mol Cell Biol; 2022 Nov; 14(6):. PubMed ID: 35803579
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mutant p53 leads to low-grade IFN-I-induced inflammation and impairs cGAS-STING signalling in mice.
    Qin Z; Liu H; Sheng Q; Dan J; Wu X; Li H; Wang L; Zhang S; Yuan C; Yuan H; Wang H; Zhou R; Luo Y; Xie X
    Eur J Immunol; 2023 Sep; 53(9):e2250211. PubMed ID: 37377275
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Manganese facilitated cGAS-STING-IFNI pathway activation induced by ionizing radiation in glioma cells.
    He Y; Yang Y; Huang W; Yang S; Xue X; Zhu K; Tan H; Sun T; Yang W
    Int J Radiat Biol; 2023; 99(12):1890-1907. PubMed ID: 37406172
    [TBL] [Abstract][Full Text] [Related]  

  • 30. cGAS exacerbates Schistosoma japonicum infection in a STING-type I IFN-dependent and independent manner.
    Liang L; Shen Y; Hu Y; Liu H; Cao J
    PLoS Pathog; 2022 Feb; 18(2):e1010233. PubMed ID: 35108342
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cyclic dinucleotides mediate bacterial immunity by dinucleotide cyclase in
    Lu Z; Fu Y; Zhou X; Du H; Chen Q
    Front Microbiol; 2022; 13():1065945. PubMed ID: 36619988
    [TBL] [Abstract][Full Text] [Related]  

  • 32. cGAS-STING signaling.
    Sun Z; Hornung V
    Curr Biol; 2022 Jul; 32(13):R730-R734. PubMed ID: 35820380
    [TBL] [Abstract][Full Text] [Related]  

  • 33. SARS-CoV-2, HIV, and HPV: Convergent evolution of selective regulation of cGAS-STING signaling.
    Shen S; Rui Y; Wang Y; Su J; Yu XF
    J Med Virol; 2023 Jan; 95(1):e28220. PubMed ID: 36229923
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Role of micronucleus-activated cGAS-STING signaling in antitumor immunity.
    Shen Q; Xu P; Mei C
    Zhejiang Da Xue Xue Bao Yi Xue Ban; 2024 Jan; 53(1):25-34. PubMed ID: 38273467
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The role of the cGAS-STING signaling pathway in viral infections, inflammatory and autoimmune diseases.
    Wang MM; Zhao Y; Liu J; Fan RR; Tang YQ; Guo ZY; Li T
    Acta Pharmacol Sin; 2024 Jun; ():. PubMed ID: 38822084
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Human plasmacytoid dentritic cells elicit a Type I Interferon response by sensing DNA via the cGAS-STING signaling pathway.
    Bode C; Fox M; Tewary P; Steinhagen A; Ellerkmann RK; Klinman D; Baumgarten G; Hornung V; Steinhagen F
    Eur J Immunol; 2016 Jul; 46(7):1615-21. PubMed ID: 27125983
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Identification of (-)-Epigallocateshin gallate derivatives promoting innate immune activation via 2',3'-cyclic GMP-AMP-stimulator of interferon genes pathway.
    Lee H; Jeong JH; Lee T; Chong Y; Choo H; Lee S
    Bioorg Med Chem Lett; 2023 Jun; 90():129325. PubMed ID: 37182610
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Regulation of cGAS-STING signalling in cancer: Approach for combination therapy.
    Vasiyani H; Wadhwa B; Singh R
    Biochim Biophys Acta Rev Cancer; 2023 May; 1878(3):188896. PubMed ID: 37088059
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ectopic expression of cGAS in
    Waanders L; van der Donk LEH; Ates LS; Maaskant J; van Hamme JL; Eldering E; van Bruggen JAC; Rietveld JM; Bitter W; Geijtenbeek TBH; Kuijl CP
    J Immunother Cancer; 2023 Apr; 11(4):. PubMed ID: 37072345
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Interaction between the SFTSV envelope glycoprotein Gn and STING inhibits the formation of the STING-TBK1 complex and suppresses the NF-κB signaling pathway.
    Jia Y; Li F; Liu Z; Liu S; Huang M; Gao X; Su X; Wang Z; Wang T
    J Virol; 2024 Mar; 98(3):e0181523. PubMed ID: 38421179
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.